BridgeMD
New treatment option for Supraspinatus Tear
Official title Treatment of the Biceps With Concomitant Supraspinatus Tears
ClinicalTrials.gov ID: NCT05660031
What this study is testing
- What it's testing
- The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective...
- Full thickness tear of the supraspinatus tendon
- Intact subscapularis tendon
- Primary rotator cuff repair
- Age 50-80
You likely can't join if
- Previous full thickness biceps tear
- Infection and neuropathic joints
- Known or suspected non-compliance, drug or alcohol abuse
- Patients incapable of judgement or under tutelage
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for MRI scan etc.
- Enrolment of the investigator, his/her family members, employees and other dependent persons
See the full eligibility criteria
- Patient voluntarily consents to participate in the study and has the mental and physical ability to participate in the study, fill out subjective questionnaires, return for follow-up visits, and comply with prescribed...
- Full thickness tear of the supraspinatus tendon
- Intact subscapularis tendon
- Primary rotator cuff repair
- Age 50-80
- Previous full thickness biceps tear
- Infection and neuropathic joints
- Known or suspected non-compliance, drug or alcohol abuse
- Patients incapable of judgement or under tutelage
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, contraindication for MRI scan etc.
- Enrolment of the investigator, his/her family members, employees and other dependent persons
- Patient declines to participate in study
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
- Portland, Oregon, United States
- Calgary, Alberta, Canada
- Meyrin, Canton of Geneva, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States; Portland, Oregon, United States; Calgary, Alberta, Canada; Meyrin, Canton of Geneva, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.